B1 | Antimicrobial resistance: The environmental impact

  - indicates presentation available

Presentation: How Johnson & Johnson is addressing pharmaceuticals in the environment 

Speaker Dr. Daniel Caldwell, Toxicology Fellow - Johnson & Johnson

Daniel Caldwell is a toxicologist and environmental scientist with decades of work experience addressing complex human and environmental health issues. In addition to being the chief scientist for Johnson & Johnson Global Environment, Health, Safety, and Sustainability, he is an adjunct Professor at Temple University College of Engineering, where he leads research on water & wastewater treatment for emerging contaminants and teaches classes on aquatic toxicology and sustainability in environmental engineering. Dan is actively engaged in the PIE issue and has numerous publications on the topic.

-----

Presentation: AMR through the back door: Exploring the links between pollution in the pharmaceutical supply chain and the global rise in antimicrobial resistance 

Speaker Natasha Hurley, Campaign Manager - Changing Markets

Changing Markets is an organisation which helps create and support targeted campaigns to drive deep transformation of the economy towards environmentally and socially beneficial products and companies. Before joining Changing Markets in 2015, Natasha spent four years working as a Campaigner at the Environmental Investigation Agency (EIA) in London, where she advocated for a global phase-out of hydrofluorocarbons (HFCs) and travelled the world representing EIA at UN climate and ozone conferences. As EU Policy Advisor at Carbon Market Watch from 2010-2011, she played an instrumental part in the campaign to ban environmentally unsound carbon offsets from the EU Emissions Trading System. Previous roles include three years working for a leading public affairs consultancy and a spell with the European Commission in Brussels.

-----

Presentation: Reducing pharmaceutical inputs into the environment: Stewardship approaches 

Speaker Dr. Karin Helwig, Researcher - Glasgow Caledonian University

For the past 7 years,  Dr. Helwig has been researching aspects of pharmaceutical pollution in the EU PiLLS and noPILLS projects. Initially involved in monitoring residues in wastewaters and environmental waters, she became increasingly interested in stakeholder analysis, qualitative research on attitudes to medicines, the role of policy and legislation and opportunities for positive solutions. Other research interests are spatial variation in aquatic monitoring, global water management issues, environmental management and rural communities.

< Parallel sessions

 

Latest news

Health Care Without Harm (HCWH) Europe organised the first ever European Workshop on Sustainable and Healthy Food in healthcare as part of CleanMed Europe, Europe’s leading conference on sustainable healthcare.
The final day of CleanMed Europe 2016 began with a wide range of parallel sessions where participants shared ideas and best practices on a wide range of topics...
The sun came out in Copenhagen for Day 2 of CleanMed Europe 2016 as 250 delegates gathered for the continuation of the conference at the UN City.

Website by Studio Beam 2016